1. Home
  2. JJSF vs COAG Comparison

JJSF vs COAG Comparison

Compare JJSF & COAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo J & J Snack Foods Corp.

JJSF

J & J Snack Foods Corp.

HOLD

Current Price

$75.92

Market Cap

1.4B

ML Signal

HOLD

Logo Hemab Therapeutics Holdings Inc. Common Stock

COAG

Hemab Therapeutics Holdings Inc. Common Stock

N/A

Current Price

$31.00

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JJSF
COAG
Founded
1971
N/A
Country
United States
United States
Employees
1800
N/A
Industry
Specialty Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
JJSF
COAG
Price
$75.92
$31.00
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$140.00
N/A
AVG Volume (30 Days)
231.6K
252.9K
Earning Date
05-06-2026
N/A
Dividend Yield
3.67%
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$1,022,038,000.00
N/A
Revenue This Year
$0.30
N/A
Revenue Next Year
$1.70
N/A
P/E Ratio
$584.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$68.87
$27.47
52 Week High
$129.24
$38.87

Technical Indicators

Market Signals
Indicator
JJSF
COAG
Relative Strength Index (RSI) 51.14 48.05
Support Level $72.93 $27.47
Resistance Level $78.42 $38.87
Average True Range (ATR) 2.52 3.96
MACD 0.13 0.21
Stochastic Oscillator 44.32 30.96

Price Performance

Historical Comparison
JJSF
COAG

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.

About COAG Hemab Therapeutics Holdings Inc. Common Stock

Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.

Share on Social Networks: